Optilume® for panurethral stricture: the good, the bad, and the ridiculous

Authors

  • Lukas Andrius Jelisejevas Department of Urology, Medical University Innsbruck, Innsbruck, Austria
  • Gennadi Tulchiner Department of Urology, Medical University Innsbruck, Innsbruck, Austria
  • Peter Rehder Department of Urology, Medical University Innsbruck, Innsbruck, Austria

DOI:

https://doi.org/10.2340/sju.v61.46024

Keywords:

Drug-coated balloon dilation, paclitaxel, urethral stricture, urethroplasty, urethral reconstruction, direct vision internal urethrotomy, DVIU

Downloads

Download data is not yet available.

References

Kulkarni S, Kulkarni J, Surana S, et al. Management of panurethral stricture. Urol Clin North Am. 2017;44:67–75. DOI: https://doi.org/10.1016/j.ucl.2016.08.011

Jeffery N, Mundy A. Innovations in indwelling urethral catheterisation. BJU Int. 2020;125:664–668. DOI: https://doi.org/10.1111/bju.14994

VanDyke ME, Morey AF, Coutinho K, et al. Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial. BJUI Compass. 2024;5:366–373. DOI: https://doi.org/10.1002/bco2.312

DeLong J, Virasoro R, Pichardo M, Estrella R, Rodríguez Lay R, Espino G, Elliott S. Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study. J Urol. 2025 Jan;213(1):90-98. Epub 2024 Aug 30. PMID: 39213367; PMCID: PMC12708045.

Estaphanous P, Khalifa AO, Makar Y. Efficacy and Safety of Optilume Drug-Coated Balloon for Urethral Stricture Treatment: A Systematic Review and Meta-Analysis. Cureus. 2024 Nov 20;16(11):e74069. PMID: 39712830; PMCID: PMC11660187. DOI: https://doi.org/10.7759/cureus.74069

Jelisejevas LA, Wassermann J, Tulchiner G, et al. Optilume drug-coated balloon for acute urinary retention after failed treatment for complex recurrent urethral stricture disease. Medicina. 2025;61:700. DOI: https://doi.org/10.3390/medicina61040700

Jelisejevas LA, Tulchiner G, Rehder P. Optilume drug-coated balloon dilation for male sphincteric (membranous) urethral strictures: 53 consecutive cases. J Clin Med. 2025;14:8369. DOI: https://doi.org/10.3390/jcm14238369

Patel HV, Erickson BA, Abbasi B, et al. Early real-world experience with optilume drug-coated balloon for anterior urethral strictures and posterior urethral stenoses. Urology. 2025;383:S0090-4295(25)01012-X.

Nordanstig J, James S, Andersson M, et al. Mortality with paclitaxel-coated devices in peripheral artery disease. N Engl J Med 2020;383:2538–2546. DOI: https://doi.org/10.1056/NEJMoa2005206

Downloads

Published

2026-05-11

How to Cite

Jelisejevas, L. A., Tulchiner, G., & Rehder, P. (2026). Optilume® for panurethral stricture: the good, the bad, and the ridiculous. Scandinavian Journal of Urology, 61(1), 166–169. https://doi.org/10.2340/sju.v61.46024

Issue

Section

Publications